New Mexico Travel Size Lysol Could Affect US Travel Linked to Lymphoma Linked with Lymphosarcoma
The World Health Organization has identified a new Lymphomas outbreak in New Mexico linked to the use of travel size Lysols.
The World Health Organization says the outbreak, which started in late February, has been linked to Lysulose Lactans (TSL), a product made by LactoseFree Lactase.
The LTB Group, which has a medical director, has denied any wrongdoing and says TSL is safe for all individuals.
However, an official from the LTB Company, which is based in New York City, told the AP that TSL “has not been tested for human exposure, and there is no evidence of human exposure in any product.”
According to the WHO, the outbreak is the first case in the U.S. to be linked to TSL, and the LGB Group claims that it has been tested in China, Australia and the United Kingdom.
The company told ABC News that it does not have a testing facility in New Jersey and is currently reviewing the risk for all its products.
However the WHO says TSl has not been evaluated for human safety and does not meet all the criteria for the use on humans.
New Mexico’s governor, Susana Martinez, said that the use is “unsafe, dangerous and unacceptable.”
“This is the most serious health risk we have seen,” Martinez said in a statement.
“Our health system needs to focus on the most critical priority: treating and managing this devastating disease.”
In the US, TSL has been approved by the FDA for use on both adults and children.
However this does not guarantee that TSl will be safe for the general population.
According to the FDA, TSl is not recommended for children and adults under 12 years old because it can cause birth defects and other serious side effects.
The FDA warns that TSls use on adults and their infants can lead to significant adverse effects including:Headaches, confusion, sleep problems, depression, seizures, and even death.
The TSL company has since issued a recall of approximately 2 million packages of TSl.
The state’s largest TSL distributor, United States-based LTB, has also announced that it will cease all TSl sales.